Autolus Therapeutics (NASDAQ:AUTL – Get Rating) and Compugen (NASDAQ:CGEN – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Insider & Institutional Ownership 66.6% of Autolus Therapeutics shares are […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Autolus Therapeutics (NASDAQ:AUTL – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations […]
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Insider and Institutional Ownership 70.1% of Autolus Therapeutics shares are owned […]
Seagen (NASDAQ:SGEN – Get Rating) and Autolus Therapeutics (NASDAQ:AUTL – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 86.3% of Seagen shares are held by […]
- Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR - AUTO1/22 may reduce CD19 negative escape in children with B-ALL, and may have broader applications in. | April 4, 2023